The purpose of this study is to determine if the study drug, inhaled nitric oxide (iNO), when given and breathed through an investigational study device, the INOpulse, may help treat patients at risk for pulmonary hypertension-pulmonary fibrosis. Another purpose of this study is to determine if using the INOpulse delivery device (drug and device combination) improves the levels of moderate to vigorous physical activity (for example walking, climbing stairs, household chores and cleaning and, exercise and hobbies), as measured by actigraphy (a non-invasive way to monitor rest/activity).
Nathalie Foray, DO is a pulmonologist in SIU’s Division of Pulmonary and Critical Care Medicine. She completed her residency and pulmonary medicine fellowship at Southern Illinois University in Springfield, IL and completed further subspeciality training in Critical Care Medicine at The University of Tennessee Health Sciences Center in Memphis, TN. Upon graduating, she joined on as faculty at SIU. In addition to providing care in the intensive care setting, Dr. Foray also sees pulmonary patients in the outpatient setting. She treats a myriad of patients in pulmonary medicine, including but not